USPTO serial 75278270
STANLEY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 1999
- Examiner
- JENKINS JR, CHARLES L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with STANLEY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
North Vancouver, British Columbia, CA
North Vancouver, British Columbia, CA
North Vancouver, British Columbia, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
RAUER L MEYER
RAUER L MEYER THELEN MARRIN JOHNSON & BRIDGES LLP2 EMBARCADERO CTRSAN FRANCISCO, CA 94111-3995UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | effervescent artificial sweetening agent in tablet and powder form | SECTION 8 - CANCELLED | — |
| 005 | analgesics, namely, acetaminophen, acetylsalicylic acid, enteric coated acetylsalicylic acid, ibuprofen, acetaminophen, caffeine and codeine preparations, analgesic balm for topical application; cold and decongestant preparations, namely, medication for colds, hay fever and allergies; narcotics and controlled drugs, namely, codeine linctus, codeine phosphate syrup, cough syrup with codeine, opium tincture, phenobarbital, terpin hydrate and codeine elixir; medicated skin preparations, namely, hydrocortisone cream, medicated ointment for the treatment of ringworm of the scalp, medicated ointment for the treatment of skin irritation of the buttocks, perineal skin cleanser, perineal protection ointment, cold sore ointment and eczema ointment; pharmaceutical preparations, namely, aminophylline, chloral hydrate, folic acid, quinidine sulfate, quinine sulfate, sulfadiazine, ferrous gluconate, ferrous sulfate, namely, an astringent salt used as a tonic in medication, glutamic acid used in hydrochloric capsules for use as a gastric acidifier; specialized hospital products, namely, chlorhexidine gluconate solution used in calcium vitamins and mineral vitamins, docusate solution, docusate sodium preparations used as a stool softener, docusate sodium solution used as a stool softener, iodine used as an antiseptic and rubefacient, oral citrate solution; vitamin and mineral supplements; first aid products, namely, rubbing alcohol compound, alum powder, boric acid powder for use as an antiseptic, calamine lotion, camphor spirit used as an analgesic, camphorated oil, castor oil, citric acid powder used in cough syrups, acetaminophen syrups and as an acidifying agent, clove oil used as an analgesic, epsom salts, eucalyptus oil used as an antiseptic, balsam solution, namely, friar's balsam for use as an inhalant for bronchitis and as a local application for small fissures, glucose used in herbal vitamins, glycerin used in cough syrup preparations and in preparations for use in capsules, gelatin capsules and lotions, green soap tincture, hydrogen peroxide solution used as an antiseptic, hydrophillic petrolatum used as a water absorbable ointment base, iodine solution used as an antiseptic, isopropanol used as a topical antiseptic, isopropyl rubbing alcohol, lanolin used in zinc creams and analgesic cream preparations, merbromin, liquid petrolatum mineral oil used in vaginal ovules, as light body rub and for constipation relief, peppermint essence used as flavoring in lozenges and antacid products and the like, liniment, sodium bicarbonate tablets used for heartburn relief, sulfur ointment, distilled water, wintergreen oil for use as a flavoring in first aid products, witch hazel distilled extract, zinc oxide ointment for use in treating skin disorders; anti-diarrheal medication; laxative medication, antacid medication; anti-nausea and vomiting preparations | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by STANLEY PHARMACEUTICALS LTD.
- Other trademarks owned by STANLEY PHARMACEUTICALS LTD.
- Other trademarks owned by STANLEY PHARMACEUTICALS LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named STANLEY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2006 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 20, 1999 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 7, 1999 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jun 7, 1999 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 4, 1999 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 10, 1998 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 27, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 5, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 1997 | DOCK | ASSIGNED TO EXAMINER | — |